Skip to Main content Skip to Navigation
Journal articles

Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.

Xavier B. Pivot 1, 2 
1 Service d'Oncologie Médicale [CHRU Besançon]
2 RIGHT - Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098)
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-00479713
Contributor : Philippe Saas Connect in order to contact the contributor
Submitted on : Sunday, May 2, 2010 - 12:48:24 PM
Last modification on : Friday, January 14, 2022 - 3:08:17 AM

Identifiers

  • HAL Id : inserm-00479713, version 1
  • PUBMED : 17683176

Collections

INSERM | UNIV-FCOMTE

Citation

Xavier B. Pivot. Bevacizumab in first-line treatment of metastatic breast cancer: a viewpoint by Xavier Pivot.. Drugs, Springer Verlag, 2007, 67 (12), pp.1800-1. ⟨inserm-00479713⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

41